This proposal describes a 5 year training program for the development of an academic career Pulmonary Sciences, Critical Care Medicine and Immunology. The principal investigator has completed structured fellowship in Pulmonary and Critical Care Medicine at the University of Colorado. He expand his scientific skills through integration of interdepartmental resources. This program will promote the in-depth understanding of immunology as applied to pulmonary Drs. Fontenot and O'Brien will both serve as mentors for the principal investigator's scientific development. Dr. Fontenot is a highly regarded expert in T cell-mediated lung disease. Dr. O'Brien is recognized international leader in v5 T cell research. Together, Drs. Fontenot and O'Brien have trained numerous clinician scientists, postdoctoral fellows and graduate students. In addition, an advisory committee highly-regarded scientists in the fields of interstitial lung disease will provide scientific and career Research will focus on the mechanisms by which ap T cells promote while y5 T lymphocytes development of pulmonary fibrosis. Recent work in the laboratory has demonstrated that mice repeatedly inhale the Gram-positive microorganism, Bacillus subtilis, develop large numbers of and y5 T cells in the lung and pulmonary fibrosis. The proposed experiments are designed to examine role of each T cell subset in the generation of pulmonary fibrosis using adoptive transfer techniques transgenic mice with T cell receptor targeted deletions. Subsequently, the mechanisms by which cell subset promotes or delays the development of pulmonary fibrosis will be investigated using in vivo and vitro cellular techniques.
The specific aims i nclude: 1. Determe if ap T cells promote deposition in the lungs of mice repeatedly exposed to B. subtilis and 2. Delineate the immunoregulatory role of v5 T cells in this murine model of hypersensitivity pneumonitis and pulmonary fibrosis. This the first detailed investigation of the role of different T cell subsets in the generation of pulmonary The University of Colorado and National Jewish Medical Research Center through their strong and Integrated Department of Immunology provides young investigators a fertile environment to highest level of basic science research from which to build an independent academic career.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL089766-05
Application #
8098819
Study Section
Special Emphasis Panel (ZHL1-CSR-O (M1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2007-07-15
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
5
Fiscal Year
2011
Total Cost
$132,316
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Simonian, Philip L; Wehrmann, Fabian; Roark, Christina L et al. (2010) ?? T cells protect against lung fibrosis via IL-22. J Exp Med 207:2239-53
Simonian, Philip L; Roark, Christina L; Wehrmann, Fabian et al. (2009) IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis. J Immunol 182:6540-9
Simonian, Philip L; Roark, Christina L; Wehrmann, Fabian et al. (2009) Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol 182:657-65
Simonian, Philip L; Roark, Christina L; Born, Willi K et al. (2009) Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis. Transl Res 154:222-7
Roark, Christina L; Simonian, Philip L; Fontenot, Andrew P et al. (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20:353-7